Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Formulation and delivery of itraconazole to the brain using a nanolipid carrier system

Authors Lim WM, Rajinikanth PS, Mallikarjun C, Kang YB

Received 14 November 2013

Accepted for publication 22 December 2013

Published 2 May 2014 Volume 2014:9(1) Pages 2117—2126

DOI https://doi.org/10.2147/IJN.S57565

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Wei Meng Lim,1 Paruvathanahalli Siddalingam Rajinikanth,2 Chitneni Mallikarjun,1 Yew Beng Kang1

1School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia; 2School of Pharmacy, Taylor’s University, Selangor, Malaysia

Abstract: The objectives of this study were to develop and characterize itraconazole (ITZ)-loaded nanostructured lipid carriers (NLCs) and to study their potential for drug delivery into the brain. Precirol® ATO 5 and Transcutol® HP were selected as the lipid phase, and Tween® 80 and Solutol® HS15 as surfactants. The ITZ-NLCs were prepared by a hot and high-pressure homogenization method. The entrapment efficiency for the best formulation batch was analyzed using high-performance liquid chromatography and was found to be 70.5%±0.6%. The average size, zeta potential, and polydispersity index for the ITZ-NLCs used for animal studies were found to be 313.7±15.3 nm, –18.7±0.30 mV, and 0.562±0.070, respectively. Transmission electron microscopy confirmed that ITZ-NLCs were spherical in shape, with a size of less than 200 nm. Differential scanning calorimetry and X-ray diffractometry analysis showed that ITZ was encapsulated in the lipid matrix and present in the amorphous form. The in vitro release study showed that ITZ-NLCs achieved a sustained release, with cumulative release of 80.6%±5.3% up to 24 hours. An in vivo study showed that ITZ-NLCs could increase the ITZ concentration in the brain by almost twofold. These results suggest that ITZ-NLCs can be exploited as nanocarriers to achieve sustained release and brain-targeted delivery.

Keywords: lipid nanoparticles, brain delivery, nanostructured lipid carrier

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

Ricciardi GRR, Russo A, Franchina T, Ferraro G, Adamo V

OncoTargets and Therapy 2015, 8:289-294

Published Date: 2 February 2015

Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer

Axiak-Bechtel SM, Upendran A, Lattimer JC, Kelsey J, Cutler CS, Selting KA, Bryan JN, Henry CJ, Boote E, Tate DJ, Bryan ME, Katti KV, Kannan R

International Journal of Nanomedicine 2014, 9:5001-5011

Published Date: 28 October 2014

Functionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles

Wood NJ, Maddocks SE, Grady HJ, Collins AM, Barbour ME

International Journal of Nanomedicine 2014, 9:4145-4152

Published Date: 27 August 2014

Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy

Liu L, Liu X, Xu Q, Wu P, Zuo X, Zhang J, Deng H, Wu Z, Ji A

International Journal of Nanomedicine 2014, 9:3509-3526

Published Date: 29 July 2014

Enhanced antifungal efficacy of tebuconazole using gated pH-driven mesoporous nanoparticles

Mas N, Galiana I, Hurtado S, Mondragón L, Bernardos A, Sancenón F, Marcos MD, Amorós P, Abril-Utrillas N, Martínez-Máñez R, Murguía JR

International Journal of Nanomedicine 2014, 9:2597-2606

Published Date: 23 May 2014

Biological augmentation of rotator cuff repair using bFGF-loaded electrospun poly(lactide-co-glycolide) fibrous membranes

Zhao S, Zhao J, Dong S, Huangfu X, Li B, Yang H, Zhao J, Cui W

International Journal of Nanomedicine 2014, 9:2373-2385

Published Date: 14 May 2014

Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis

Zhang YT, Shen LN, Zhao JH, Feng NP

International Journal of Nanomedicine 2014, 9:669-678

Published Date: 23 January 2014

Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery

Liu J, Liu J, Xu H, Zhang Y, Chu L, Liu Q, Song N, Yang C

International Journal of Nanomedicine 2014, 9:197-207

Published Date: 24 December 2013

Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay

Li Q, Qi H, Zhou HX, Deng CY, Zhu H, Li JF, Wang XL, Li FR

International Journal of Nanomedicine 2011, 6:2175-2181

Published Date: 29 September 2011